Suppr超能文献

α2 自身受体和α2 异源受体对大鼠脑内酪氨酸和色氨酸羟化酶活性的体内调节:α2 肾上腺素能受体亚型的研究

Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes.

作者信息

Esteban S, Lladó J, García-Sevilla J A

机构信息

Departament de Biologia Fonamental i Ciències de la Salut, Universitat de les Illes Balears, Palma de Mallorca, Spain.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1996 Mar;353(4):391-9. doi: 10.1007/BF00261435.

Abstract

The subtype determination of auto- and hetero-alpha 2-adrenoceptors modulating the synthesis of noradrenaline (NA) and serotonin (5-HT), respectively, was assessed using the accumulation of 3,4-dihydroxyphenylalanine (dopa) and 5-hydroxytryptophan (5-HTP) after decarboxylase inhibition as a measure of the rate of tyrosine and tryptophan hydroxylation in the rat brain in vivo. In the cerebral cortex and hippocampus, Org 3770 (non-selective alpha 2-adrenoceptor antagonist, 0.5-10 mg/kg, i.p.) increased (43%-58%) and clonidine (non-selective alpha 2-adrenoceptor agonist, 1 mg/kg) decreased (37%-49%) the synthesis of dopa. Also the antagonist ARC 239 (alpha 2B/C selective, 5-40 mg/kg) increased the synthesis of dopa in cortex (39%-46%) and hippocampus (17%-85%). In contrast, the antagonist BRL 44408 (alpha 2D selective, 1-10 mg/kg) did not increase the synthesis of dopa in cortex, and increased it modestly in hippocampus only. The agonist guanoxabenz (alpha 2B/C selective, 0.03-3 mg/kg) decreased the synthesis of dopa in both brain regions (20%-65%), whereas the agonist oxymetazoline (alpha 2D selective, 0.1-3 mg/kg) failed to do so. These results indicated that the alpha 2-autoreceptors that modulate the synthesis of dopa/NA are probably associated with the alpha 2B/C-subtypes. In cortex and hippocampus, clonidine decreased (35%-53%) the synthesis of 5-HTP but Org 3770 failed to induce the opposite effect (except the 2 mg/kg dose in cortex). BRL 44408 markedly increased the synthesis of 5-HTP in cortex (113%-148%) but not in hippocampus. Similarly, also ARC239 increased the formation of 5-HTP in cortex (36%-48%) but not in hippocampus, where it was decreased (30%-55%). Oxymetazoline decreased the synthesis of 5-HTP in hippocampus (28%-30%) but failed to do so in cortex. Guanoxabenz in the low dose range (0.03-0.3 mg/kg) did not decrease the synthesis of 5-HTP in any brain region. These results indicated that the alpha 2-heteroreceptors that modulate the synthesis of 5-HTP/5-HT may well be different from the proposed alpha 2B/C-autoreceptors modulating the synthesis of dopa/NA. These alpha 2-heteroreceptors appear to be associated with the alpha 2D-subtype.

摘要

通过抑制脱羧酶后3,4 - 二羟基苯丙氨酸(多巴)和5 - 羟色氨酸(5 - HTP)的积累,来评估分别调节去甲肾上腺素(NA)和5 - 羟色胺(5 - HT)合成的自身和异源α2 - 肾上腺素能受体的亚型,以此作为体内大鼠脑中酪氨酸和色氨酸羟化速率的指标。在大脑皮层和海马体中,Org 3770(非选择性α2 - 肾上腺素能受体拮抗剂,0.5 - 10 mg/kg,腹腔注射)使多巴合成增加(43% - 58%),可乐定(非选择性α2 - 肾上腺素能受体激动剂,1 mg/kg)使多巴合成减少(37% - 49%)。同样,拮抗剂ARC 239(α2B/C选择性,5 - 40 mg/kg)使大脑皮层(39% - 46%)和海马体(17% - 85%)中的多巴合成增加。相反,拮抗剂BRL 44408(α2D选择性,1 - 10 mg/kg)未增加大脑皮层中多巴的合成,仅在海马体中略有增加。激动剂胍那苄(α2B/C选择性,0.03 - 3 mg/kg)使两个脑区的多巴合成减少(20% - 65%),而激动剂奥昔麻黄碱(α2D选择性,0.1 - 3 mg/kg)则未起到此作用。这些结果表明,调节多巴/NA合成的α2 - 自身受体可能与α2B/C亚型相关。在大脑皮层和海马体中,可乐定使5 - HTP合成减少(35% - 53%),但Org 并不能诱导相反的效果(大脑皮层中2 mg/kg剂量除外)。BRL 44408显著增加大脑皮层中5 - HTP的合成(113% - 148%),但在海马体中未增加。同样,ARC239增加大脑皮层中5 - HTP的生成(36% - 48%),但在海马体中未增加,反而使其减少(30% - 55%)。奥昔麻黄碱使海马体中5 - HTP的合成减少(28% - 30%),但在大脑皮层中未起到此作用。低剂量范围(0.03 - 0.3 mg/kg)的胍那苄未使任何脑区的5 - HTP合成减少。这些结果表明,调节5 - HTP/5 - HT合成的α2 - 异源受体可能与调节多巴/NA合成的α2B/C - 自身受体不同。这些α2 - 异源受体似乎与α2D亚型相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验